整合炎症生物标志物的诺莫图预测慢性阻塞性肺病恶化后康复
Ping Lv1, Xinyu Zhao2, Hongyun Zhang3
1Department of Respiratory and Critical Care Medicine, Second Medical Center, Chinese PLA General Hospital, Beijing, 100853, China. s30100ping@163.com.
BMC pulmonary medicine
|February 10, 2026
概括
整合全身炎症生物标志物的新诺莫格拉姆模型可以预测慢性阻塞性肺病 (COPD) 患者肺复原后急性恶化风险. 关键指标包括中性粒细胞与淋巴细胞的比率 (NLR),血小板与淋巴细胞的比率 (PLR) 和埃索诺菲尔的百分比.
科学领域:
- 肺部医学 肺部医学
- 炎症生物标志物 炎症生物标志物
- 预测建模预测建模
背景情况:
- 慢性阻塞性肺病 (COPD) 给健康带来了重大挑战,急性恶化会影响患者的预后.
- 肺部康复是COPD管理的基石,但预测康复后恶化风险仍然至关重要.
研究的目的:
- 开发和验证一个名目录模型,用于预测COPD患者肺部康复后急性恶化风险.
- 确定关键的系统性炎症生物标志物,与康复后恶化风险相关.
主要方法:
- 一组358名接受肺部康复治疗的COPD患者被追溯分析.
- 收集了系统性炎症生物标志物和临床数据;患者被分为培训 (70%) 和验证 (30%) 组.
- 多变量逻辑回归和LASSO回归确定了名ogram构建和验证的独立预测因子.
主要成果:
- 纳米图纳入了中性粒细胞与淋巴细胞的比率 (NLR),血小板与淋巴细胞的比率 (PLR),hs-CRP,乙素百分比,CAT得分,mMRC和FEV1%的预测.
- 该模型表现出良好的区分能力,在训练组中AUC为0.774,在验证组中为0.731.
- 校准曲线证实了预测和观察到的恶化风险之间的良好一致性.
结论:
- 开发的诺米图有效预测COPD患者肺部康复后急性恶化风险.
- 血小板与淋巴细胞的比率 (PLR),中性粒细胞与淋巴细胞的比率 (NLR) 和氨基酸的百分比是重要的预测指标.
- 该模型为COPD患者的个性化风险评估和管理策略提供了有价值的工具.
相关概念视频
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.2K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.2K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.3K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.3K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K